Related references
Note: Only part of the references are listed.Lymphadenectomy in endometrial cancer Reply
Henry Kitchener et al.
LANCET (2009)
A cost-effective analysis of adjuvant therapies for the treatment of stage I endometrial adenocarcinoma
Jason A. Lachance et al.
GYNECOLOGIC ONCOLOGY (2008)
Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study
Nobuyuki Susumu et al.
GYNECOLOGIC ONCOLOGY (2008)
The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology
D. S. Chi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Vaginal brachytherapy versus external beam pelvic radiotherapy for high-intermediate risk endometrial cancer: Results of the randomized PORTEC-2 trial
R. A. Nout et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Systematic Pelvic Lymphadenectomy vs No Lymphadenectomy in Early-Stage Endometrial Carcinoma: Randomized Clinical Trial
Pierluigi Benedetti Panici et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Identifying stage III colorectal cancer patients: The influence of the patient, surgeon, and pathologist
Eva Judith Ann Morris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma
David E. Cohn et al.
OBSTETRICS AND GYNECOLOGY (2007)
Patterns of practice and outcomes in intermediate- and high-risk stage I and II endometrial cancer: a population-based study
J. S. Kwon et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Cost-Effectiveness Analysis of Treatment Strategies for Stage I and II Endometrial Cancer
Janice S. Kwon et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2007)
Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology
Christopher V. Lutman et al.
GYNECOLOGIC ONCOLOGY (2006)
Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study
ME Randall et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer
JM Cragun et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Lymph node evaluation in colorectal cancer patients: A population-based study
NN Baxter et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients:: The postoperative radiation therapy in endometrial carcinoma trial
CL Creutzberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study
HM Keys et al.
GYNECOLOGIC ONCOLOGY (2004)
Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation
J Fanning et al.
GYNECOLOGIC ONCOLOGY (2004)
High-risk surgical stage 1 endometrial cancer: outcomes with vault brachytherapy alone
PVC Rittenberg et al.
GYNECOLOGIC ONCOLOGY (2003)
Conservative management of stage I endometrial carcinoma after surgical staging
JM Straughn et al.
GYNECOLOGIC ONCOLOGY (2002)
Long-term survival of intermediate risk endometrial cancer (Stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy
J Fanning
GYNECOLOGIC ONCOLOGY (2001)
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma:: multicentre randomised trial
CL Creutzberg et al.
LANCET (2000)
Share Paper
